VANGUARD GROUP INC 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale |
2023-12-29 | 13G | Avanos Medical, Inc. AVNS |
VANGUARD GROUP INC | 5,417,952 11.670% |
-82,048 (-1.49%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Avanos Medical, Inc. AVNS |
VANGUARD GROUP INC | 5,500,000 11.830% |
278,214 (+5.33%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Avanos Medical, Inc. AVNS |
VANGUARD GROUP INC | 5,221,786 10.840% |
211,891 (+4.23%) |
Filing |
| 2021-06-10 10:06 am Purchase |
2021-05-28 | 13G | Avanos Medical, Inc. AVNS |
VANGUARD GROUP INC | 5,009,895 10.420% |
671,982 (+15.49%) |
Filing |
| 2021-02-10 10:39 am Sale |
2020-12-31 | 13G | Avanos Medical, Inc. AVNS |
VANGUARD GROUP INC | 4,337,913 9.070% |
-202,349 (-4.46%) |
Filing |